LYEL

NASDAQStock

Lyell Immunopharma, Inc.

$21.26-3.52 (-14.19%)

52-Week Range

$7.80
$38.60

Key Stats

Market Cap

451.6M

P/E Ratio

Dividend Yield

Beta

-0.15

Volume

103.1K

Avg Volume

111.3K

Performance

1M

-4.12%

3M

-23.53%

6M

+87.41%

YTD

-14.51%

1Y

+139.56%

3Y

-43.44%

5Y

-92.67%

Price Chart

ETF Exposure

LYEL is held by 23 ETFs

ETFFund NameWeight
NIFEDirexion Fallen Knives ETF0.63%
DWASInvesco Dorsey Wright SmallCap Momentum ETF0.30%
IBBQInvesco Nasdaq Biotechnology ETF0.04%
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.04%
BIBProShares - Ultra Nasdaq Biotechnology0.03%
AVSCAvantis U.S. Small Cap Equity ETF0.02%
IBBiShares Biotechnology ETF0.01%
SCHASchwab U.S. Small-Cap ETF0.01%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.01%
VXFVanguard Extended Market ETF0.00%
VHTVanguard Health Care ETF0.00%
DFASDimensional - US Small Cap ETF0.00%
DXUVDimensional - US Vector Equity ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
AVUSAvantis U.S. Equity ETF0.00%
DFACDimensional - US Core Equity 2 ETF0.00%
DFAUDimensional - US Core Equity Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%

About LYEL ETF Exposure

Lyell Immunopharma, Inc. (LYEL) is held by 23 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 451.6M, LYEL is a widely held institutional stock. The stock currently trades at $21.26. Investors can gain exposure to LYEL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LYEL, sorted by portfolio weight.